Pharmaceutical Market Event Impact Analysis


At KMK, we have the resources and experience to not only help you better prepare for the unexpected but to be proactive when faced with new market dynamics.

No matter how well you understand the market or how many promotional plans you have prepared, the market is continually evolving and impacting your efforts and expectations. Unexpected events like a generic product outage might result in significant adoption of your product, while a pandemic like COVID 19 might diminish demand for your product and even shrink your market size. How you respond to these market impacts can make or break you.

To help you quickly build up a strategic plan towards the new market events, our Market Event Impact Analysis team will partner with you to quickly build a strategic plan focused on the new market events, leveraging all the data available for evaluation and quantifying the short- and long-term impacts. We will help you quickly identify the optimum customer targets and the channels and activities you should put in place to best reach those targets to win a head start against your competition.

Learn more about our Marketing Tactics

Related insights

Associate, Commercial Analyst C00373

Senior Data Analyst Consultant, C00311

Consultant, Commercial Performance C00283

Associate, Business Analyst C00377

Senior Consultant, Commercial Analytics, C00101

Todd Foster

KMK Consulting Inc. Names Todd Foster as Principal of Client Services and Innovation

KMK Consulting Inc. Welcomes Bob Swann as Global Market Access Associate Principal

Smarter Real World Evidence

Elevating Primary Research Segmentation: The Future Ahead

Men’s Health Matters: Overcoming Stigma and Prioritizing Wellness

Data Rx: Your Prescribed Solution to Achieve Strategic Objectives in Emerging Pharma

Closing The Gap: 5 Key Drivers to Meet Unmet Medical Needs

KMK Consulting Inc. Earns Third Consecutive US Great Place to Work Certification™ in 2023!

KMK Solves the Puzzle of Product Commercialization with New Logo Launch

KMK 2023 Annual Award Ceremony

KMK Consulting Inc. Welcomes Paul Cariola as Lead Principal, Commercial Strategy

KMK Patient Journey Analysis Leads Global Pharma Brand To More Accurate Forecasting

The Patient Journey: Transforming Healthcare into Patientcare

Renee Daniels Named Global Head of Recruitment and HR at KMK Consulting Inc.

The Art of Leadership in the Emerging Biopharmaceutical Industry: Trends, Challenges, and Approaches

KMK Names Healthcare Veteran Stephen Deitch as Head of Global Market Access

The First Seven Miles – A Rare Disease Patient Journey

KMK Consulting Inc Appoints Chris Stevenson as Principal of Strategy in Europe

Sr. Associate, Advanced Analytics C00229

Associate, Data Analyst C00292

Senior Associate, Advanced Analytics C00300

Pharma 2023: Redefining the Roadmap Through a Commercial Lens

Data Analyst C00228

Drive Better Results: Using Technology in Your Product Commercialization Planning

Associate Consultant C00295

HEOR & RWE: The Path to Effective Drug Development

Forecasting in CAR T- Cell Therapy Assists in Setting Client Expectations for Patient Deliveries

Analytics Lead C00296

The Significance of Considering Psychological Aspects of Diabetes Patient Care

Uncovering an Accurate Target Call List for a Drug Treating Sickle Cell Disease  

Strategic Planning for Medical Affairs: Adding Value Efficiently

How We Promote Work-Life Flexibility

Associate Consultant, Data Science C00288

KMK Consulting Inc. Earns 2022 Great Place to Work-Certification in India! 

Latest Research Breakthroughs in Prostate Cancer Treatment 

Manager, Commercial Analytics C00104

KMK Names Shanique Turner as Director of Market Research

KMK Consulting Inc. Named 2022 Best Company for Women to Work

Now Is The Time To Use An Interactive Flow Diagram To Tell Patient Narratives

Supporting an Emerging Pharma Company’s Product Launch with an Integrated, End-to-End Data Management Platform 

Data Science & Stats Associate C00277

Big Data Analyst C00281

Developing an Incentive Compensation Plan To Better Attract, Motivate and Retain Sales Personnel Serving the Rare Disease Market 

Associate Consultant C00293

Associate Consultant, IT C00274

Associate C00275

Associate Consultant, Data Science C00272

Associate Consultant, Data Science C00271

Great Place to Work Certification

KMK Celebrates Being Certified as a “Great Place to Work” in USA & India

KMK Consulting Welcomes New Market Research Principal, Dan DeSantis

Ready, Set, Launch – Why Technology is Key to a Successful Product Launch

How To Avoid Costly Mistakes In Pre-launch?

Data Assessment In Action

Access Granted Webinar: Transforming the Customer Access Landscape

Senior Associate, HEOR C00113

Manager, Commercial Analytics C00104

Lead Analyst C00106

Director, Commercial Analytics C00102

Data Scientist C00103

Commercial Analytics Consultant 258

Associate Data Analytics 589

Associate Director C00226

Analytics Manager C00105

KMK Consulting Inc. Donates to Underprivileged Children in India

The Invisible Customer: How Private Equity Owned Practices are Changing the Biopharma Industry

KMK Consulting Inc. Announces Dani Heywood as President

Vakhtang Agayan Named New CTO at KMK Consulting Inc.

The Art of Building a Flexible Sales Force During COVID-19

Localizing Your BioPharma Commercial Strategy

KMK Consulting, Inc. Launches On-Demand SME Network

KMK Donates to COVID Relief Effort in India


Making Remote Work in India with Pratik Panchal

KMK Consulting, Inc. Earns 2021 Great Place to Work Certification™

Erenumab Study Demonstrates Significantly Reduced Acute Medication Usage and Health Care Utilization for Migraines

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Genentech, Pfizer and Merck Identified as the Top Three Companies Driving Therapeutic Innovation in Breast Cancer

How to become the Iron Man of Data Analytics?

Exploring the significance of Real World Evidence and Real World Data

HEOR Principal Huanxue Zhou’s Manuscript in BURNS Journal

HEOR Principal Huanxue Zhou’s Manuscript in International Journal of MS Care

Gritty and Fearless: How to succeed at KMK

East Meets West: The KMK Way

Learning the Ropes: An Intern’s Story at KMK

KMK Partners with Major Pharma Company in Recent RWE Study Analyzing Multiple Sclerosis Treatment Costs

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

High Cost of Medication Tops the List of Challenges for Gastroenterologists Treating IBS